Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

By Gershoni-Baruch R.   Dagan E.   Fried G.   Bruchim Bar-Sade R.   Sverdlov-Shiri R.   Zelicksson G.   Friedman E.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 983-986

Elsevier

Access to resources Recommend Favorite

High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients

By Kwong Ava  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 605-607

Springer Publishing Company

Access to resources Recommend Favorite

Novel Germline BRCA1 and BRCA2 Mutations in Turkish Women with Breast and/or Ovarian Cancer and Their Relatives

By Egeli Unal   Cecener Gulsah   Tunca Berrin   Tasdelen Ismet  

Cancer Investigation, Vol. 24, Iss. 5, 2006-06 ,pp. : 484-491

Informa Healthcare

Access to resources Recommend Favorite

High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia

By Torres Diana   Rashid Muhammad Usman   Gil Fabian   Umana Angela   Ramelli Giancarlo   Robledo Jose Fernando   Tawil Mauricio   Torregrosa Lilian   Briceno Ignacio   Hamann Ute  

Breast Cancer Research and Treatment, Vol. 103, Iss. 2, 2007-06 ,pp. : 225-232

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect

By Muller Danièle   Bonaiti-Pelié Catherine   Abecassis Joseph   Stoppa-Lyonnet Dominique   Fricker Jean-Pierre  

Familial Cancer, Vol. 3, Iss. 1, 2004-01 ,pp. : 15-20

Springer Publishing Company

Access to resources Recommend Favorite